Wegovy maker Novo Nordisk sales rise 18% in second quarter

Wegovy-maker Novo Nordisk reported second-quarter sales up 18% on Wednesday, below initial analyst expectations, after a major profit warning and new CEO announcement last week wiped some $95 billion of value from the company's stock.

Also Read: Doustdar Takes Helm at Novo Nordisk Amidst Market Challenges

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)